The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease
-
Vesna Bacic-Vrca
Abstract
The effects of supplementation with a fixed combination of antioxidants (vitamins C and E, β-carotene and selenium) on superoxide dismutase activity, copper and zinc concentrations, and total antioxidant status were monitored in erythrocytes derived from a group of patients with Graves' disease treated with methimazole, with respect to the rate of achieving euthyroidism. Thyroid-stimulating hormone (TSH), thyroid hormones and the above-mentioned parameters were measured before therapy, and on days 30 and 60 after therapy initiation. The patients receiving antioxidant supplementation along with methimazole therapy (group A, n=27) achieved euthyroidism at a faster rate than those treated with methimazole alone (group B, n=28). The activity of superoxide dismutase decreased significantly in both patient groups during the treatment; however, there was no significant difference between the groups. There was no significant change in the erythrocyte concentration of copper, whereas the zinc concentration and total antioxidant status showed significant between-group differences. The study results clearly show that antioxidant supplementation in the treatment of Graves' disease is justified, while zinc and total antioxidant status in erythrocytes seem to be sensitive indicators of the efficacy of supplemental therapy.
References
1 Mano T, Shinohra R, Sawai Y, Oda N, Nishida T, Mokuno T, et al. Effects of thyroid hormone on coenzyme Q and other free radical scavengers in rat heart muscle. J Endocrinol 1995; 145: 131–6. 10.1677/joe.0.1450131Suche in Google Scholar
2 Carrion Y, Fernandez V, Videla LA. Influence of thyroid hormone administration on hepatic glutathione content and basolateral γ-glutamyltransferase ectoactivity in the isolated perfused rat liver. Biochem Pharmacol 1993; 45: 2527–35. 10.1016/0006-2952(93)90234-NSuche in Google Scholar
3 Fernandez V, Simizu K, Barros SB. Effects of hyperthyroidism on rat liver glutathione metabolism: related enzyme activities, efflux, and turnover. Endocrinology 1991; 129: 85–91. 10.1210/endo-129-1-85Suche in Google Scholar
4 Fernandez V, Barrientos X, Kipreos K, Valenzuela A, Videla LA. Superoxide radical generation, NADPH oxidase activity and cytochrome P-450 content of rat liver microsomal fraction in experimental hyperthyroid state: relation to lipid peroxidation. Endocrinology 1985; 117: 496–501. 10.1210/endo-117-2-496Suche in Google Scholar
5 Mano T, Iwase K, Hayashi R, Hayakawa N, Uchimura K, Makino M, et al. Vitamin E and coenzyme Q concentrations in the thyroid tissue of patients with various thyroid disorders. Am J Med Sci 1998; 315: 230–2. Suche in Google Scholar
6 Iwase K, Nagasaka A, Kato K, Ohtani S, Tsujimura T, Inagaki A, et al. Localization of Cu/Zn superoxide dismutase in various thyroid disorders. Acta Endocrinol 1993; 129: 573–8. 10.1530/acta.0.1290573Suche in Google Scholar
7 Ozdem S, Alicigüzel Y, Ozdem SS, Karayalcin U. Effects of propylthiouracil treatment on antioxidant activities in blood of toxic multinodular goiter patients. Pharmacology 2000; 61: 31–6. 10.1159/000028377Suche in Google Scholar
8 Komosinska-Vassev K, Olczyk K, Kucharz EJ, Marcisz C, Winsz-Szczotka K, Kotulska A. Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta 2000; 300: 107–17. 10.1016/S0009-8981(00)00306-5Suche in Google Scholar
9 Seven A, Seymen O, Hatemi S, Hatemi H, Yigit G, Candan G. Antioxidant status in experimental hyperthyroidism: effect of vitamin E supplementation. Clin Chim Acta 1996; 256: 65–74. 10.1016/S0009-8981(96)06415-7Suche in Google Scholar
10 Seven A, Tasan E, Inci F, Hatemi H, Burcak G. Biochemical evaluation of oxidative stress in propylthiouracil-treated hyperthyroid patients. Effects of vitamin C supplementation. Clin Chem Lab Med 1998; 36: 767–70. 10.1515/CCLM.1998.136Suche in Google Scholar
11 Adali M, Inal-Erden M, Akalin A, Efe B. Effects of propylthiouracil, propranolol, and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients. Clin Biochem 1999; 32: 363–7. 10.1016/S0009-9120(99)00024-7Suche in Google Scholar
12 Guerra LN, Moiguer S, Karner M, De Molina MCR, Sreider CM, Burdman JA. Antioxidants in the treatment of Graves' disease. Life 2001; 51: 105–9. Suche in Google Scholar
13 Vrca VB, Skreb F, Cepelak I, Romic Z, Mayer L. Supplementation with antioxidants in the treatment of Graves' disease: the effect on glutathione peroxidase activity and concentration of selenium. Clin Chim Acta 2004; 341: 55–63. 10.1016/j.cccn.2003.10.028Suche in Google Scholar
14 Masiukiewicz US, Burrow GN. Hyperthyroidism in pregnancy: diagnosis and treatment. Thyroid 1999; 9: 647–52. 10.1089/thy.1999.9.647Suche in Google Scholar
15 Koshiyama H, Sellitti DF, Akamizu T, Doi SQ, Takeuchi Y, Inoue D, et al. Cardiomyopathy associated with Graves' disease. Clin Endocrinol 1996; 45: 111–6. 10.1111/j.1365-2265.1996.tb02068.xSuche in Google Scholar
16 Chaurasia SS, Kar A. Protective effects of vitamin E against lead-induced deterioration of membrane associated type-I iodothyronine monodeiodinase (5′D-I) activity in male mice. Toxicology 1997; 124: 203–9. 10.1016/S0300-483X(97)00155-8Suche in Google Scholar
17 Brzezinska-Slebodinzska E. Fever-induced oxidative stress: the effect on thyroid status at the 5′-monodeiodinase activity; protective role of selenium and vitamin E. J Physiol Pharmacol 2001; 52: 275–84. Suche in Google Scholar
18 Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001; 31: 1287–312. 10.1016/S0891-5849(01)00724-9Suche in Google Scholar
19 Frei B, Stocker R, England L, Ames BN. Ascorbate: the most effective antioxidant in human blood plasma. Adv Exp Med Biol 1990; 264: 155–63. 10.1007/978-1-4684-5730-8_24Suche in Google Scholar
20 Shull S, Heintz NH, Periasamy M, Manohar M, Janssen YM, Marsh JP, et al. Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem 1991; 266: 24398–403. 10.1016/S0021-9258(18)54242-3Suche in Google Scholar
21 Tainer JA, Getzoff ED, Richardson JS, Richardson DC. Structure and mechanism of copper, zinc superoxide dismutase. Nature 1983; 306: 284–7. 10.1038/306284a0Suche in Google Scholar
22 Aihara K, Nishi Y, Hatano S, Kihara M, Yoshimitsu K, Takeichi N, et al. Zinc, copper, manganese, and selenium metabolism in thyroid disease. Am J Clin Nutr 1984; 40: 26–35. 10.1093/ajcn/40.1.26Suche in Google Scholar
23 Taniguchi N, Ishikawa N, Kondo T. Inhibitory effect of thyroxine on carbonic anhydrase B isozyme biosynthesis in rabbit reticulocyte lysates. Biochem Biophys Res Commun 1978; 85: 952–8. 10.1016/0006-291X(78)90636-8Suche in Google Scholar
24 Liu N, Liu P, Xu Q, Zhu L, Zhao Z, Wang Z, et al. Elements in erythrocytes of population with different thyroid hormone status. Biol Trace Elem Res 2001; 84: 37–43. 10.1385/BTER:84:1-3:037Suche in Google Scholar
25 Sayama N, Yoshida K, Mori K, Fukazawa H, Hori H, Nakazato N, et al. Measurement of red blood cell zinc concentration with Zn-test kit: discrimination between hyperthyroid Graves' disease and transient thyrotoxicosis. Endocr J 1998; 45: 767–72. 10.1507/endocrj.45.767Suche in Google Scholar
26 Yoshida K, Kiso Y, Watanabe TK, Kaise K, Itagaki Y, Yamamoto M, et al. Erythrocyte zinc in hyperthyroidism: reflection of integrated thyroid hormone levels over the previous few months. Metabolism 1990; 39: 182–6. 10.1016/0026-0495(90)90073-LSuche in Google Scholar
27 Abuja PM, Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta 2001; 306: 1–17. 10.1016/S0009-8981(01)00393-XSuche in Google Scholar
28 Vrca VB, Skreb F, Cepelak I, Mayer Lj. Supplementation with antioxidants in the treatment of Graves' disease: the effect on the extracellular antioxidative parameters. Acta Pharm 2004; 54: 79–89. Suche in Google Scholar
© by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Autoantibodies against intrinsic factor (IF) measured with an ELISA using recombinant human IF as both catching and detecting reagent
- Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis
- Fucosylation of serum glycoproteins in lung cancer patients
- Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus
- α-Tocopherol as an antiretroviral therapy supplement for HIV-1-infected patients for increased lymphocyte viability
- The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease
- Concentrations of calcium, copper, iron, magnesium, potassium, sodium and zinc in adult female hair with different body mass indexes in Taiwan
- Estimation of the limit of detection with a bootstrap-derived standard error by a partly non-parametric approach. Application to HPLC drug assays
- Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry
- How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?
- An iterative method for improved estimation of the mean of peer-group distributions in proficiency testing
- Impact of a common CV evaluation scheme on overall laboratory performance: 8-year experience of a large national proficiency testing program in Japan
- Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations
- Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein
- Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality
- Erythrocyte ferritin concentration: analytical performance of the immunoenzymatic IMx-Ferritin (Abbott) assay
- Vitamin C and aberrant electrolyte results
- POX-ACT assay and d-ROMs test: comparison impossible
- A spectrophotometric micromethod for determining erythrocyte protoporphyrin-IX in whole blood or erythrocytes
Artikel in diesem Heft
- Autoantibodies against intrinsic factor (IF) measured with an ELISA using recombinant human IF as both catching and detecting reagent
- Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis
- Fucosylation of serum glycoproteins in lung cancer patients
- Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus
- α-Tocopherol as an antiretroviral therapy supplement for HIV-1-infected patients for increased lymphocyte viability
- The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease
- Concentrations of calcium, copper, iron, magnesium, potassium, sodium and zinc in adult female hair with different body mass indexes in Taiwan
- Estimation of the limit of detection with a bootstrap-derived standard error by a partly non-parametric approach. Application to HPLC drug assays
- Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry
- How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?
- An iterative method for improved estimation of the mean of peer-group distributions in proficiency testing
- Impact of a common CV evaluation scheme on overall laboratory performance: 8-year experience of a large national proficiency testing program in Japan
- Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations
- Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein
- Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality
- Erythrocyte ferritin concentration: analytical performance of the immunoenzymatic IMx-Ferritin (Abbott) assay
- Vitamin C and aberrant electrolyte results
- POX-ACT assay and d-ROMs test: comparison impossible
- A spectrophotometric micromethod for determining erythrocyte protoporphyrin-IX in whole blood or erythrocytes
